MoneyWorks4Me

Ambalal Sarabhai Ent reports Profit after tax of Rs 11.16 Mln, in the March 2023 quarter

30 May 2023 Evaluate
The total revenue hovered 191.34% to Rs. 3.70 millions for the March 2023 quarter as against Rs. 1.27 millions during the corresponding quarter last year.The Total Profit for the quarter ended March 2023 of Rs. 11.16 millions grew from Rs.-104.18 millionsOperating Profit reported a sharp decline to 20.48 millions from 52.51 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 3.70 1.27 191.34 37.07 1.27 2818.90 37.07 1.27 2818.90
Other Income 33.46 67.70 -50.58 105.34 395.35 -73.36 105.34 395.35 -73.36
PBIDT 20.48 52.51 -61.00 53.76 339.68 -84.17 53.76 339.68 -84.17
Interest 0.48 1.26 -61.90 1.07 2.47 -56.68 1.07 2.47 -56.68
PBDT 12.55 -98.39 -112.76 44.81 36.44 22.97 44.81 36.44 22.97
Depreciation 0.26 0.48 -45.83 1.45 1.92 -24.48 1.45 1.92 -24.48
PBT 12.29 -98.87 -112.43 43.36 34.52 25.61 43.36 34.52 25.61
TAX 1.13 5.31 -78.72 2.26 4.96 -54.44 2.26 4.96 -54.44
Deferred Tax 1.13 7.81 -85.53 2.26 7.46 -69.71 2.26 7.46 -69.71
PAT 11.16 -104.18 -110.71 41.10 29.56 39.04 41.10 29.56 39.04
Equity 766.33 766.33 0.00 766.33 766.33 0.00 766.33 766.33 0.00
PBIDTM(%) 553.51 4134.65 -86.61 145.02 26746.46 -99.46 145.02 26746.46 -99.46
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..